Literature DB >> 34311781

Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders.

Primus Che Chi1, Esther Awuor Owino2, Irene Jao2, Fredrick Olewe3,4, Bernhards Ogutu3,4, Philip Bejon2,5, Melissa Kapulu2,5, Dorcas Kamuya2,5, Vicki Marsh2,5.   

Abstract

BACKGROUND: Human infection studies (HIS) that involve deliberately infecting healthy volunteers with a pathogen raise important ethical issues, including the need to ensure that benefits and burdens are understood and appropriately accounted for. Building on earlier work, we embedded social science research within an ongoing malaria human infection study in coastal Kenya to understand the study benefits and burdens experienced by study stakeholders in this low-resource setting and assess the wider implications for future research planning and policy.
METHODS: Data were collected using qualitative research methods, including in-depth interviews (44), focus group discussions (10) and non-participation observation. Study participants were purposively selected (key informant or maximal diversity sampling), including volunteers in the human infection study, study staff, community representatives and local administrative authorities. Data were collected during and up to 18 months following study residency, from sites in Coastal and Western Kenya. Voice recordings of interviews and discussions were transcribed, translated, and analysed using framework analysis, combining data- and theory-driven perspectives.
FINDINGS: Physical, psychological, economic and social forms of benefits and burdens were experienced across study stages. Important benefits for volunteers included the study compensation, access to health checks, good residential living conditions, new learning opportunities, developing friendships and satisfaction at contributing towards a new malaria vaccine. Burdens primarily affected study volunteers, including experiences of discomfort and ill health; fear and anxiety around aspects of the trial process, particularly deliberate infection and the implications of prolonged residency; anxieties about early residency exit; and interpersonal conflict. These issues had important implications for volunteers' families, study staff and the research institution's reputation more widely.
CONCLUSION: Developing ethically and scientifically strong HIS relies on grounded accounts of volunteers, study staff and the wider community, understood in the socioeconomic, political and cultural context where studies are implemented. Recognition of the diverse, and sometimes perverse, nature of potential benefits and burdens in a given context, and who this might implicate, is critical to this process. Prior and ongoing stakeholder engagement is core to developing these insights.
© 2021. The Author(s).

Entities:  

Keywords:  Benefits; Burdens; Challenge studies; Controlled human infection studies; Developing countries; Ethics; Human infection studies

Year:  2021        PMID: 34311781     DOI: 10.1186/s13063-021-05455-7

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.279


  22 in total

1.  What makes clinical research in developing countries ethical? The benchmarks of ethical research.

Authors:  Ezekiel J Emanuel; David Wendler; Jack Killen; Christine Grady
Journal:  J Infect Dis       Date:  2004-02-17       Impact factor: 5.226

2.  Ethical Criteria for Human Challenge Studies in Infectious Diseases.

Authors:  Ben Bambery; Michael Selgelid; Charles Weijer; Julian Savulescu; Andrew J Pollard
Journal:  Public Health Ethics       Date:  2015-09-27       Impact factor: 1.940

Review 3.  Experimental infection of human volunteers.

Authors:  Meta Roestenberg; Marie-Astrid Hoogerwerf; Daniela M Ferreira; Benjamin Mordmüller; Maria Yazdanbakhsh
Journal:  Lancet Infect Dis       Date:  2018-06-18       Impact factor: 25.071

4.  Challenge studies of human volunteers: ethical issues.

Authors:  T Hope; J McMillan
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

5.  Human challenge trials in vaccine development, Rockville, MD, USA, September 28-30, 2017.

Authors:  Marc F D Baay; Thomas L Richie; Pieter Neels
Journal:  Biologicals       Date:  2018-03-21       Impact factor: 1.856

Review 6.  Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy.

Authors:  Euzebiusz Jamrozik; Michael J Selgelid
Journal:  J Med Ethics       Date:  2020-05-07       Impact factor: 2.903

Review 7.  COVID-19 human challenge studies: ethical issues.

Authors:  Euzebiusz Jamrozik; Michael J Selgelid
Journal:  Lancet Infect Dis       Date:  2020-05-29       Impact factor: 25.071

8.  Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity.

Authors:  Melissa C Kapulu; Patricia Njuguna; Mainga M Hamaluba
Journal:  Wellcome Open Res       Date:  2019-11-14

9.  Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan-based malaria infection study.

Authors:  Irene Jao; Vicki Marsh; Primus Che Chi; Melissa Kapulu; Mainga Hamaluba; Sassy Molyneux; Philip Bejon; Dorcas Kamuya
Journal:  Bioethics       Date:  2020-07-09       Impact factor: 1.898

10.  A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, Malawi.

Authors:  Stephen B Gordon; Jamie Rylance; Amy Luck; Kondwani Jambo; Daniela M Ferreira; Lucinda Manda-Taylor; Philip Bejon; Bagrey Ngwira; Katherine Littler; Zoe Seager; Malick Gibani; Markus Gmeiner; Meta Roestenberg; Yohannie Mlombe
Journal:  Wellcome Open Res       Date:  2017-08-24
View more
  4 in total

Review 1.  Systems biology of malaria explored with nonhuman primates.

Authors:  Mary R Galinski
Journal:  Malar J       Date:  2022-06-07       Impact factor: 3.469

2.  Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt.

Authors:  Noni Mumba; Patricia Njuguna; Primus Chi; Vicki Marsh; Esther Awuor; Mainga Hamaluba; Cynthia Mauncho; Salim Mwalukore; Johnson Masha; Mary Mwangoma; Betty Kalama; Hassan Alphan; Juliana Wambua; Philip Bejon; Dorcas Kamuya; Melissa C Kapulu
Journal:  Front Public Health       Date:  2022-04-29

3.  Considering the Importance of Context for Ethical Practice on Reimbursement, Compensation and Incentives for Volunteers in Human Infection Controlled Studies.

Authors:  Primus Che Chi; Esther Owino; Irene Jao; Vicki Marsh; Dorcas Kamuya
Journal:  Am J Bioeth       Date:  2021-03       Impact factor: 14.676

4.  Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.

Authors:  Primus Che Chi; Esther Awuor Owino; Irene Jao; Philip Bejon; Melissa Kapulu; Vicki Marsh; Dorcas Kamuya
Journal:  BMC Med Ethics       Date:  2022-04-20       Impact factor: 2.834

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.